Medicare's AI Prior Authorization Trial Cuts Medical Services Fast
Medicare deployed AI to pre-approve patient care, and the move quickly resulted in a significant reduction in medical services utilized.
Medicare has begun testing artificial intelligence to handle prior authorizations, a process that determines whether patients receive approval for specific medical treatments or procedures before they are performed. The experiment represents a notable shift in how the federal health program manages spending oversight, targeting what officials describe as wasteful or unnecessary medical utilization.
The rollout produced immediate and measurable results: medical services dropped sharply once the AI-driven system took over pre-approval decisions. The speed and scale of that decline has drawn attention from patient advocates, healthcare providers, and policy analysts who are closely watching how automated decision-making affects access to care for Medicare beneficiaries.
Read more Senate Races This Fall Could Shape Social Security's Future →
Prior authorization has long been a contested mechanism in American healthcare. Insurers and government payers argue it curbs unnecessary procedures and controls costs, while physicians and patient groups contend it creates dangerous delays and administrative burdens. Introducing AI into that process raises the stakes considerably, as algorithmic denials could affect millions of seniors who depend on Medicare for their primary coverage.
The pilot underscores a broader federal push to leverage technology in reducing healthcare expenditures, which remain among the largest drivers of the national budget. Whether the drop in services reflects the elimination of genuinely unnecessary care or the inappropriate denial of needed treatment is a question that will likely define the policy debate going forward.
Continue reading at MarketWatch.com
